# PIPERACILLIN AND TAZOBACTAM
> **ANDA065523** · Abbreviated New Drug Application (Generic) · Sponsor: ISTITUTO BIO ITA SPA · Approved 2011-05-31
## Drug
- **FDA Application Number:** ANDA065523
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PIPERACILLIN AND TAZOBACTAM
- **Generic name:** PIPERACILLIN SODIUM,TAZOBACTAM SODIUM
- **Active ingredients:** PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ISTITUTO BIO ITA SPA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2011-05-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065523)
---
*AI Analytics · CC0 1.0*